期刊
BIOMEDICINE & PHARMACOTHERAPY
卷 93, 期 -, 页码 788-795出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2017.07.037
关键词
6-Gingerol; Endothelial cell; Diabetes mellitus; Nitric oxide; Phosphatidylinositol 3-kinase
资金
- Natural Scientific Foundation of China [31660323, 81070633, 30860111, 30660058]
- Department of Science Technology [20123BCB22005]
6-Gingerol (6-Gin), an active constituent of Zingiber officinale, has been reported to have antiinflammatory, anti-oxidative, anti-cancerous etc. bioactivities. However, little is known about its endothelial protective effects and the underlying mechanisms. In this study, our purpose was to investigate the protective effects of 6-Gin and its underlying mechanisms. HUVECs were exposed to high glucose (HG, 33 mM glucose) for 48 h, followed by 50 mu M 6-Gin with or without LY294002 (10 mu M), AKT inhibitor IV (0.5 mu M) or L-NAME (5 mM) for another 24 h. Cell viability, levels of NO, LDH and ROS were detected. In addition, the expression levels of IKK, IRS-1, PI3 K, AKT, eNOS and their phosphorylated proteins were measured by western blots. Compared with the control, HUVECs were significantly impaired by HG, characterized by decreased levels of the cell viability, NO, pY458-PI3 K, pS473-AKT and pS1177-eNOS while increased levels of LDH, pS176-IKK, and p-S312-IRS-1. Conversely, 6-Gin remarkably protected HUVECs against HG-induced injury in a concentration-and time-dependent manner. However, the protective effects of 6-Gin were abolished by co-treatment with LY294002, AKT inhibitor IV or LNAME at the HG state. Collectively, 6-Gin attenuated the injury of HUVECs induced by HG through the activation of PI3K-AKT-eNOS signal pathway. The findings provide a novel potential for 6-Gin to prevent and treat the angiopathy resulting from diabetes mellitus. (C) 2017 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据